Number of the records: 1  

lymfocyty infiltrujúce nádor

  1. SYSd016246
    LBL
      
    00000cx--j2200000---45--
    005
      
    20240119201255.9
    100
      
    $a 19920606asloy0103----ba0
    152
      
    $b mesh
    250
      
    $a lymfocyty infiltrujúce nádor $x CH $x CL $x CY $x DE $x EN $x IM $x ME $x MI $x PA $x PH $x PS $x RE $x TR $x UL $x VI $8 slo
    300
    1-
    $a 91 $8 eng
    300
    1-
    $a Lymphocytes (1976-1990) $8 eng
    300
    1-
    $a T-Lymphocytes (1977-1990) $8 eng
    300
    1-
    $a T-Lymphocytes, Cytotoxic (1984-1990) $8 eng
    330
    1-
    $a Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer. $8 eng
    450
      
    $a Tumor Infiltrating Lymphocyte $5 e $8 eng
    450
      
    $a Tumor-Derived Activated Cell $5 e $8 eng
    450
      
    $a Tumor-Derived Activated Cells $5 e $8 eng
    450
      
    $a Tumor-Infiltrating Lymphocyte $5 e $8 eng
    450
      
    $a Tumor-Infiltrating Lymphocytes $5 e $8 eng
    450
      
    $a lymfocyt infiltrujúci nádor $5 e $8 slo
    450
      
    $a tumor infiltrujúce lymfocyty $5 e $8 slo
    450
      
    $a nádor-infiltrujúce leukocyty $5 e $8 slo
    450
      
    $a bunky pochádzajúce z nádoru, aktivované $5 e $8 slo
    450
      
    $a bunky odvodené od nádoru, aktivované $5 e $8 slo
    550
      
    $3 sllk_un_auth*d016219 $Y Immunotherapy, Adoptive $5 F $a imunoterapia adoptívna
    686
      
    $a A11.118.637.555.567.650
    686
      
    $a A15.145.229.637.555.567.650
    686
      
    $a A15.382.490.555.567.650
    750
      
    $a Lymphocytes, Tumor-Infiltrating $8 eng
    801
    -0
    $a US $b DNLM $c 19920606
    801
    -2
    $a SK $b BA006 $c 20011012
    801
    -2
    $a SK $b BA006 $c 20211117
    820
      
    $a subpopulations: coordinate with LYMPHOCYTE SUBSETS or specifics $8 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.